Episode 355

Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 3 with Dr Sara M Tolaney

Featuring perspectives from Dr Sara M Tolaney, including the following topics:

  • Mechanistic effects and potential resistance mechanisms of antibody-drug conjugates (0:00)
  • First-line treatment of metastatic triple-negative breast cancer (mTNBC) in patients eligible for immunotherapy (7:13)
  • First-line treatment of mTNBC in patients ineligible for immunotherapy (13:02)
  • Antibody-drug conjugates for previously treated HER2-low metastatic breast cancer (19:15)

CME information and select publications

About the Podcast

Show artwork for Oncology Today with Dr Neil Love
Oncology Today with Dr Neil Love
A Research To Practice Podcast for Oncology Clinicians

Listen for free